Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Editor's Choice for June 2016

Prof Gordon McVie - ecancer Editor in Chief
Editor's Choice for June 2016 ( Prof Gordon McVie - ecancer Editor in Chief )
29 Jun 2016

Results from the EURO-SKI cessation trial of TKIs in CML

Dr Johan Richter - Lund University, Lund, Sweden
Results from the EURO-SKI cessation trial of TKIs in CML ( Dr Johan Richter - Lund University, Lund, Sweden )
23 Jun 2016

Mutations associated with imatinib response in CML

Katerina Machova Polakova - Institute of Hematology and Blood Transfusion, Prague, Czech Republic
Mutations associated with imatinib response in CML ( Katerina Machova Polakova - Institute of Hematology and Blood Transfusion, Prague, Czech Republic )
20 Jun 2016

Latest in precision cancer medicine

Prof Richard Schilsky - Chief Medical Officer, ASCO
Latest in precision cancer medicine ( Prof Richard Schilsky - Chief Medical Officer, ASCO )
15 Jun 2016

Specific mutations in leukaemia patients' blood predicts survival

Dr Klaus Metzeler - University of Munich, Munich, Germany
Specific mutations in leukaemia patients' blood predicts survival ( Dr Klaus Metzeler - University of Munich, Munich, Germany )
12 Jun 2016

Causes and consequences of microRNA dysregulation in cancer

Prof Carlo Croce - Ohio State University, Columbus, USA
Causes and consequences of microRNA dysregulation in cancer ( Prof Carlo Croce - Ohio State University, Columbus, USA )
12 Jun 2016

Sequencing multiple myeloma reveals a complex landscape of genetic lesions

Dr Niccolo Bolli - University of Milan, Milan, Italy
Sequencing multiple myeloma reveals a complex landscape of genetic lesions ( Dr Niccolo Bolli - University of Milan, Milan, Italy )
12 Jun 2016

Results from SCHOLAR-1 trial for DLBCL patients

Prof Christian Gisselbrecht - LYSARC, Pierre-Bénite, France
Results from SCHOLAR-1 trial for DLBCL patients ( Prof Christian Gisselbrecht - LYSARC, Pierre-Bénite, France )
12 Jun 2016

Super-enhancer analysis reveals subtypes in AML and MDS

Dr Michael McKeown - Syros Pharmaceuticals, Cambridge, USA
Super-enhancer analysis reveals subtypes  in AML and MDS ( Dr Michael McKeown - Syros Pharmaceuticals, Cambridge, USA )
12 Jun 2016

PD-1 enhances elotuzumab efficacy

Dr Natalie Bezman - Bristol-Meyers Squibb, Princeton, USA
PD-1 enhances elotuzumab efficacy ( Dr Natalie Bezman - Bristol-Meyers Squibb, Princeton, USA )
12 Jun 2016

Novel therapies for older patients with AML and MDS

Prof Naval Daver - MD Anderson Cancer Center, Houston, United States
Novel therapies for older patients with AML and MDS ( Prof Naval Daver - MD Anderson Cancer Center, Houston, United States )
12 Jun 2016

Better screening programmes needed for haematological malignancies such as leukaemia

Dr Brigitte Schlegerberger - Hannover Medical School, Hannover, Germany
Better screening programmes needed for haematological malignancies such as leukaemia ( Dr Brigitte Schlegerberger - Hannover Medical School, Hannover, Germany )
12 Jun 2016